Nantes-based Ose Immunotherapeutics has temporarily suspended trials of a Covid-19 vaccine. A decision made by the company following an initial side-effect assessment conducted on healthy volunteers participating in this trial, which began in late May. BUT “precautionary measure” explains the company.
Nantes explains that they made this decision when a number of “Limited side effects” was emphasized in patients participating in the study after preliminary examination. This includes persistent nodules at the injection sitebut “no pain, no inflammation, no fever,” Ose Immunotherapeutics points out in a press release.
Therefore, the company will track the evolution of these nodules until decide if a clinical trial should be resumed… “As always, our top priority remains the safety and well-being of patients.” accurate “As always, our top priority remains the safety and well-being of patients.” clarifies Alexis Peyroles, Managing Director.
This trial includes about fifty volunteerspreviously vaccinated or not vaccinated with an approved vaccine. Ose Immunotherapeutics vaccine aims to “cover all current and future SARS-CoV-2 variants”